Experienced in Fibrosarcoma

Motoshi Wada

Sendai, JP 
Experienced in Fibrosarcoma
Sendai, JP 
OverviewLocationsClinical Research

Overview

Motoshi Wada practices in Sendai, Japan. Wada is rated as an Experienced expert by MediFind in the treatment of Fibrosarcoma. Their top areas of expertise are Short Bowel Syndrome, Biliary Atresia, Jaundice, Liver Transplant, and Small Bowel Resection.

Their clinical research consists of co-authoring 89 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Fibrosarcoma.

Locations

Sendai, Japan
Other Locations
Tokyo, Japan
Wako, 3510198, Japan
Tsukuba, 3050006, Japan
3050801, Japan
Kyoto, 6100321, Japan
Kyotanabe, 6100321, Japan
Tohoku, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Japanese Pediatric Subjects With Short Bowel Syndrome Who Completed SHP633-302
A Prospective, Open-label, Long-term Safety and Efficacy Study of Teduglutide in Japanese Pediatric Subjects With Short Bowel Syndrome Who Completed SHP633-302
Enrollment Status: Completed
Publish Date: May 24, 2022
Intervention Type: Drug
Study Drug: Teduglutide
Study Phase: Phase 3
A 24-week Safety, Efficacy, Pharmacodynamic, and Pharmacokinetic Study of Teduglutide in Japanese Pediatric Subjects, Aged 4 Months Through 15 Years, With Short Bowel Syndrome Who Are Dependent on Parenteral Support
A 24-week Safety, Efficacy, Pharmacodynamic, and Pharmacokinetic Study of Teduglutide in Japanese Pediatric Subjects, Aged 4 Months Through 15 Years, With Short Bowel Syndrome Who Are Dependent on Parenteral Support
Enrollment Status: Completed
Publish Date: February 02, 2022
Intervention Type: Drug
Study Phase: Phase 3
A 24-Week Safety, Efficacy, Pharmacokinetic Study of Teduglutide in Japanese Subjects With Short Bowel Syndrome Who Are Dependent on Parenteral Support
A 24-Week Safety, Efficacy, Pharmacokinetic Study of Teduglutide in Japanese Subjects With Short Bowel Syndrome Who Are Dependent on Parenteral Support
Enrollment Status: Completed
Publish Date: August 04, 2020
Intervention Type: Drug, Device
Study Phase: Phase 3
View 2 Less Clinical Trials

89 Total Publications

Bile Leakage after Liver Transplantation Owing to Stricture of Afferent Jejunal Loop Caused by an Intussusception Valve after Biliary Atresia Surgery: A Case Report.
Bile Leakage after Liver Transplantation Owing to Stricture of Afferent Jejunal Loop Caused by an Intussusception Valve after Biliary Atresia Surgery: A Case Report.
Journal: Surgical case reports
Published: April 01, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Wada's expertise for a condition
ConditionClose
    View All 20 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile